London, May 9, 2026, 23:06 (BST)
- Compass Group PLC will report 2026 half-year results at 7 a.m. BST on Monday, with management due to present at 9 a.m. and take questions after the webcast.
- CPG shares were marked at sell $29.51 and buy $29.52 after Friday’s session, up 0.73%, with the market closed, Hargreaves Lansdown data showed.
- The company last reaffirmed 2026 guidance for around 10% underlying operating profit growth at constant currency, helped by around 7% organic revenue growth and M&A.
Compass Group PLC heads into Monday’s half-year results with investors focused on whether the catering group can keep its 2026 profit target intact while defending growth in workplace dining, technology clients and its newly enlarged European business.
The timing matters. The update is due before investors get a fresh full trading day in London, and the shares have already moved to a U.S. dollar quote after Compass switched its London Stock Exchange trading currency from sterling pence on April 1. The company said that move would reduce foreign-exchange volatility in the share price and would not affect its LSE listing or FTSE index inclusion.
Compass enters the print with some room to defend the story. In February, it said first-quarter organic revenue — growth from the existing business, excluding the main effects of acquisitions and currency — rose 7.3%, with North America up 7.3% and International up 7.1%. Client retention was above 96%, annualised new business wins reached $4 billion, and Business & Industry grew by double digits in North America.
Consensus is close to management’s line. Compass’s own analyst consensus, last updated on March 2, points to 7.2% organic revenue growth in fiscal 2026, revenue of $50.5 billion and underlying operating profit of $3.72 billion. Underlying profit is the company’s adjusted profit measure; constant currency means before exchange-rate translation effects.
Chief Executive Dominic Blakemore told analysts in February that Compass had made a “strong start to the year,” while finance chief Petros Parras said volumes added about half a percentage point in the first quarter. Blakemore also said net new business could see a modest second-half lift if retention stays strong.
The harder question is sentiment. Reuters reported in February that Compass shares fell even after a revenue beat as investors weighed the possible effect of artificial intelligence on office-based clients. About 20% of Compass revenue comes from technology, professional and financial services clients, and Blakemore told analysts then that he saw “more opportunity than risk” from AI. Reuters
That issue did not go away. In the February call, management said 80% of the portfolio sat in sectors such as sports, defence, mining, manufacturing, education and healthcare, which it described as largely insulated from AI risk. Analysts including Leo Carrington at Citi and Ivar Billfalk-Kelly at UBS pressed management on office exposure and what lower attendance could mean for contract economics.
M&A will be the other live item. Compass completed the $1.7 billion purchase of Dutch food-services business Vermaat in December, part of $1.9 billion of first-quarter M&A investment. Management has framed the deal as a way to add capability in Europe and copy a North American acquisition playbook, but Parras told analysts it was still too early to give detail on the integration.
The sector backdrop is mixed, not forgiving. French peer Sodexo cut its 2026 sales and margin targets in April, citing execution challenges and a review of contracts and assets; Reuters said its shares fell 13% that day and noted Sodexo had underperformed Compass and Aramark over the prior two years. Morningstar analyst Ben Slupecki told Reuters that rising competition from Aramark may explain some of Sodexo’s U.S. weakness.
The risk for Compass is a Monday update that shows slower North American Business & Industry growth, softer client volumes, less room on margins, or a more cautious read on Vermaat. Investors are also likely to listen for any shift on GLP-1 drugs — medicines used for diabetes and weight loss — after Blakemore said in February that Compass was not seeing an impact, but could adapt menus and portion sizes if demand changed.
The company’s next scheduled trading update is July 21, with full-year results due Nov. 24. Monday’s half-year figures should show whether the February guidance still has enough cushion, or whether the debate moves back to valuation, AI-linked office demand and how fast acquisitions can pay back.
